ARMP vs. SGHT

Last updated Apr 1, 2026

Compare and contrast key facts about Armata Pharmaceuticals Inc. (ARMP) and Sight Sciences, Inc. (SGHT).

Performance

ARMP vs. SGHT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Armata Pharmaceuticals Inc. (ARMP) and Sight Sciences, Inc. (SGHT). The values are adjusted to include any dividend payments, if applicable.

ARMP vs. SGHT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ARMP Armata Pharmaceuticals Inc.	63.06%	239.46%	-42.90%	161.29%	-77.37%	44.21%
SGHT Sight Sciences, Inc.	-52.46%	117.86%	-29.46%	-57.74%	-30.51%	-47.55%

Fundamentals

Market Cap ARMP : $371.09M SGHT : $200.12M
EPS ARMP : -$4.80 SGHT : -$0.73
PS Ratio ARMP : 57.24 SGHT : 2.55
Total Revenue (TTM) ARMP : $6.48M SGHT : $77.36M
Gross Profit (TTM) ARMP : $5.00M SGHT : $66.67M
EBITDA (TTM) ARMP : -$58.74M SGHT : -$33.70M

Returns By Period

In the year-to-date period, ARMP achieves a 63.06% return, which is significantly higher than SGHT's -52.46% return.

ARMP

• 1D: 19.21%
• 1M: -4.83%
• YTD: 63.06%
• 6M: 243.62%
• 1Y: 601.37%
• 3Y*: 83.03%
• 5Y*: 16.66%
• 10Y*: -32.31%

SGHT

• 1D: 2.45%
• 1M: -26.94%
• YTD: -52.46%
• 6M: 9.59%
• 1Y: 57.08%
• 3Y*: -24.44%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ARMP vs. SGHT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARMP

ARMP Risk / Return Rank: 98
ARMP Sharpe Ratio Rank: 98
ARMP Sortino Ratio Rank: 98
ARMP Omega Ratio Rank: 97
ARMP Calmar Ratio Rank: 99
ARMP Martin Ratio Rank: 99

SGHT

SGHT Risk / Return Rank: 64
SGHT Sharpe Ratio Rank: 66
SGHT Sortino Ratio Rank: 69
SGHT Omega Ratio Rank: 67
SGHT Calmar Ratio Rank: 59
SGHT Martin Ratio Rank: 61

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARMP vs. SGHT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Armata Pharmaceuticals Inc. (ARMP) and Sight Sciences, Inc. (SGHT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ARMP	SGHT	Difference
Sharpe ratio Return per unit of total volatility	3.79	0.70	+3.09
Sortino ratio Return per unit of downside risk	4.73	1.56	+3.16
Omega ratio Gain probability vs. loss probability	1.60	1.20	+0.40
Calmar ratio Return relative to maximum drawdown	14.39	0.78	+13.62
Martin ratio Return relative to average drawdown	38.08	2.06	+36.02
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ARMP vs. SGHT - Sharpe Ratio Comparison

The current ARMP Sharpe Ratio is 3.79, which is higher than the SGHT Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of ARMP and SGHT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ARMP	SGHT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.79	0.70	+3.09
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.15	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.29	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.23	-0.41	+0.18

Correlation

The correlation between ARMP and SGHT is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ARMP vs. SGHT - Dividend Comparison

Neither ARMP nor SGHT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ARMP vs. SGHT - Drawdown Comparison

The maximum ARMP drawdown since its inception was -99.98%, roughly equal to the maximum SGHT drawdown of -96.70%. Use the drawdown chart below to compare losses from any high point for ARMP and SGHT.

Drawdown Indicators

	ARMP	SGHT	Difference
Max Drawdown Largest peak-to-trough decline	-99.98%	-96.70%	-3.28%
Max Drawdown (1Y) Largest decline over 1 year	-37.22%	-61.66%	+24.44%
Max Drawdown (5Y) Largest decline over 5 years	-85.70%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-99.84%	—	—
Current Drawdown Current decline from peak	-99.79%	-90.36%	-9.43%
Average Drawdown Average peak-to-trough decline	-82.58%	-77.43%	-5.15%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.40%	23.26%	-8.86%

Volatility

ARMP vs. SGHT - Volatility Comparison

The current volatility for Armata Pharmaceuticals Inc. (ARMP) is 32.05%, while Sight Sciences, Inc. (SGHT) has a volatility of 37.65%. This indicates that ARMP experiences smaller price fluctuations and is considered to be less risky than SGHT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARMP	SGHT	Difference
Volatility (1M) Calculated over the trailing 1-month period	32.05%	37.65%	-5.60%
Volatility (6M) Calculated over the trailing 6-month period	104.47%	64.69%	+39.78%
Volatility (1Y) Calculated over the trailing 1-year period	160.36%	82.63%	+77.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	112.19%	91.79%	+20.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	112.45%	91.79%	+20.66%

Financials